Online Magazine
Discovering diseases with artificial intelligence
With an AI-based technology, the Swiss start-up Scailyte manages to detect diseases before it is too late. In the seventh edition of our Cat!apult podcast, COO Corinne Solier explains how artificial intelligence could change the visit to the doctor forever.
by Tobias Imbach
Often, those who become seriously ill need luck in disguise: only if the diagnosis is made in time can the disease be treated successfully. Many seriously ill people are denied this – due to the complexity of many diseases.
The scientist and Scailyte COO Dr. Corinne Solier is working with her company on an AI-based technology that enables precise and rapid detection of diseases. In the Cat!apult podcast, she explains how it works and reveals her confidence about improving disease diagnostics by means of technology.
SAID & NOTED
The diagnostic of some diseases can take up to 5 to 10 years – that’s a big burden, not only in terms of physical pain, but also regarding the uncertainty of not knowing what’s wrong.
With our Scaivision platform, we are not looking for something with a predefined lens. We are allowing the platform to discover for us and find what needs to be found.
In a sense, Scaivision plays the role of a magnet finding the needle in the haystack.
Experts are still needed: to interprete the data.
Ultimately, our applications will help bring the right medicine to the right patient at the right time.
Corinne Solier
Scailyte AG, Basel/Boston
Corinne has a Master's degree in Engineering in Biotechnology and a PhD in Immunology from the Université Paul Sabatier in Toulouse, France. She completed postdoctoral studies at the City of Hope National Medical Center in the US in the field of nuclear receptor biochemistry before joining Roche Pharmaceuticals. There she held various positions in early research and development dealing with translational biomarker science, innovative "omics" technologies and innovation. Most recently, she worked for Roche as Global Head of Translational Technologies & Bioinformatics, and joined Scailyte as Chief Operating Officer in 2021.
